Generics

News

Novartis looking into future of its Sandoz' generics busines...

Novartis revealed today that it may consider divesting its generic medicines subsidiary Sandoz – amongst other options – which would further narrow its focus to innovative medicines.

Views & Analysis

The critical role of the generics sector during the pandemic

Graeme Duncan from ADVANZ PHARMA explores how successful cross-industry collaboration between pharma and generics companies has helped support supply challenges during the pandemic.

News

AstraZeneca sells rights to cholesterol drug Crestor to Grun...

AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal.

News

"Tokyo, Japan - May 11, 2012: Pfizer building on May 11, 2012 in Tokyo. Pfizer is one of largest pharmaceutical companies worldwide with tremendous revenue $67.4 bn USD for 2011. It exists since 1849."

Pfizer ups guidance as it prepares to sell off generics divi...

Pfizer has cautiously upped its guidance despite second quarter figures showing a slip in sales and profitability compared with the same period last year.

Views & Analysis

Packaged Pills in aluminium blisters stacked on each other

How generic medicines increase patient access to treatment

The UK writes the most generic prescriptions across Europe and generics play a vital role in ensuring the sustainability of the country’s healthcare sector. I

Views & Analysis

Creating sustainable access to modern medicine

It’s easy to overlook just how much the world has changed in healthcare terms over the last 40-50 years thanks to modern medicine. From the availability of antibiotics to the trans

Novartis looking into future of its Sandoz' generics busines...

The critical role of the generics sector during the pandemic

AstraZeneca sells rights to cholesterol drug Crestor to Grun...

Pfizer ups guidance as it prepares to sell off generics divi...

How generic medicines increase patient access to treatment

Creating sustainable access to modern medicine

Protego's $130m for amyloidosis drug, and other financings

How to meet your physicians where they are online

Generics

Editor's Picks